Special Contributing Faculty


Faculty members who do not serve as dissertation mentors but who make contributions to the education of our students by teaching or serving as clinical mentors are appointed as Gerstner Sloan Kettering Special Contributing Faculty.

The following is a list of current members of the contributing faculty along with their research interests:

Cameron W. Brennan
MD, Cornell University Medical College
Genomic analysis of human and mouse gliomas and medulloblastomas.

Margaret K. Callahan
MD, PhD, University of Connecticut School of Medicine
Cancer immunotherapy

Marinela Capanu
PhD, University of Florida
Epidemiology and Biostatistics
Hierarchical models in genetic association studies, misspecification tests, and survival analysis.

Aimee M. Cargo
MD, Harvard Medical School
PhD, Cambridge University (UK)
Molecular mechanisms underlying sarcomageneis.

Maura N. Dickler
MD, The University of Chicago Pritzker School of Medicine
Hormonal therapy and anti-angiogenic therapy of breast cancer.

Christian Grommes
MD, RWTH Aachen Medical School (Germany)
Aberrant signaling pathways in primary central nervous system lymphomas.

Clifford A. Hudis
MD, The Medical College of Pennsylvania
Translational clinical trials for breast cancer.

John Humm
PhD, South Bank University
Medical Physics
Molecular imaging of cancer by PET, hypoxia, and targeted radionuclide therapies, especially with tumor-specific antibodies.

Jason T. Huse
MD, PhD, University of Pennsylvania School of Medicine
Molecular pathogenesis of brain tumors, particularly malignant gliomas.

Mary L. Keohan
MD, Yale University School of Medicine
Soft Tissue Sarcoma

David S. Klimstra
MD, Yale University School of Medicine
Pathology of pancreatic, hepatobiliary, and gastrointestinal neoplasia.

Mark G. Kris
MD, Cornell University Medical College
Clinical trials and translational research.

Sohail Malik 
Rockefeller University
Biochemistry and Molecular Biology.

Robert J. Motzer
MD, University of Michigan Medical School
Clinical trials for metastatic renal cell carcinoma and germ cell tumors.

Larry Norton
MD, Columbia University College of Physicians and Surgeons
Breast Cancer clinical trials, tumor growth kinetics, and mathematics of metastasis.

Antonio M. Omuro
MD, University of Sao Paulo School of Medicine (Brazil)
Clinical trials and translational research in neuro-oncology, with emphasis on gliomas and primary CNS lymphomas.

Jae Park
MD, Johns Hopkins School of Medicine
Development of novel targeted therapy and application of immunotherapy in adult patients with hematologic malignancies.

Philip B. Paty
MD, Stanford University School of Medicine
Biomarkers — diagnostic, prognostic, predictive — for colorectal cancer.

Miguel-Angel Perales
MD, Free University of Brussels (Belgium)
Translational research in hematopoietic stem cell transplantation with a focus on immunotherapy.

Michael A. Postow
MD, New York University School of Medicine
Melanoma medical oncologist with an interest in immunotherapeutic approaches to melanoma and associated biomarker analysis.

Diane Reidy-Lagunes
MD, SUNY Downstate Medical Center
Clinican scientist with a focus on improving treatment strategies for patients with neuroendocrine tumors (NETs).

Victor E. Reuter
MD, Pedro Henriquez Urena National University (Dominican Republic)
Marker evaluation and validation in urologic cancers.

Leonard Saltz
MD, Yale University School of Medicine
Development of new therapies for colorectal cancer.

Howard I. Scher
MD, New York University School of Medicine
Mechanism-based drug development for prostate cancer.

Eytan M. Stein
MD, Northwestern University Medical School
Novel early phase therapeutics for actue myeloid leukemia, clinical trial design.

William P. Tew
MD, University of Rochester School of Medicine and Dentistry
Gynecologic cancer, developmental therapeutics, aging research/geriatic oncology.

Tiffany A. Traina
MD, Weill Cornell Medical College
Clinical trials and translational research in the field of breast cancer, specifically triple negative breast cancer and the role of the androgen receptor.

Agnes Viale
PhD, Universite de Nice-Sophia Antipolis
Genomics Core
Genomics: from microarrays to next generation sequencing.

Anas Younes
MD, The University of Damascus School of Medicine (Damascus, Syria)
Molecular targeted therapy, molecular biomarkers, mechanism based combination strategies, novel treatments of lymphomas.

Kristen Zakian
PhD, University of Pennsylvania
Medical Physics
Magnetic resonance imaging and spectroscopy to study cancer.

Pat Zanzonico
PhD, Cornell University
Medical Physics
Nuclear medicine and molecular imaging research: hypoxia imaging, targeted radionuclide therapy, and small-animal imaging.

Andrew D. Zelenetz
MD, Harvard Medical School
Clinical and translation research in lymphoma.